Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Xenova

This website has been constructed in order to provide some background information to Xenova Group Limited and a general overview of the drug development activities of the Company.Through its subsidiary, Xenova Biomanufacturing, the Company also undertakes contract manufacturing and process development at its Cambridge, UK, facility.


Contact Details:
957 Buckingham Avenue
Slough
Berkshire
SL1 4NL
United Kingdom
Tel:44 (0) 1753 706600
Fax:44 (0) 1753 706607
Email:info@xenova.com
WWW:

www.xenova.co.uk/




Loading...

Recent Publications by Xenova:

Preclinical anti-tumor activity of XR5944 in combination with carboplatin or doxorubicin in non-small-cell lung carcinoma.
XR5944 (MLN944) is a novel bis-phenazine currently in phase I clinical...
17th December, 2005
Xenova Anticancer Drugs. 2005 Oct;16(9):945-51.
Antitumour activity of XR5944 in vitro and in vivo in combination with 5-fluorouracil and irinotecan in colon cancer cell lines.
XR5944 (MLN944), a novel bis-phenazine, has demonstrated potent cytotoxic...
25th March, 2005
Xenova Ltd, 957 Buckingham Avenue, Slough, Berkshire SL1 4NL, UK. Br J Cancer. 2005 Feb 28;92(4):722-8.
DOI Direct Link
XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro.
Recent reports suggest that elevated levels of plasminogen activator...
27th October, 2004
Xenova Ltd, Anticancer Drugs. 2004 Jan;15(1):37-44.
Design and synthesis of new templates derived from pyrrolopyrimidine as selective multidrug-resistance-associated protein inhibitors in multidrug resistance.
In our continued effort to identify selective MRP1 modulators, we have...
24th April, 2004
Department of Medicinal Chemistry, Department of Pharmacology, Analytical J Med Chem. 2004 Mar 11;47(6):1339-50.
DOI Direct Link
Studies on pyrrolopyrimidines as selective inhibitors of multidrug-resistance-associated protein in multidrug resistance.
Multidrug resistance mediated by P-glycoprotein (Pgp) or...
24th April, 2004
Department of Medicinal Chemistry, Department of Pharmacology, and J Med Chem. 2004 Mar 11;47(6):1329-38.
DOI Direct Link

View more Xenova research publications.

Press Releases on Xenova:

BioPortfolio Logo
PwC BioScience Index & Share League September - October 2002 1st November, 2002 Pwc
  PwC BioScience Index & Share League September - October 2002 The PwC BioScience Index highlights the performance of UK bioscience companies
CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES MANAGEMENT APPOINTMENTS 1st June, 2001 Cat
  CAMBRIDGE ANTIBODY TECHNOLOGY (CAT) ANNOUNCES MANAGEMENT APPOINTMENTS Cambridge, UK & Cambridge Antibody Technology (LSE: CAT; NASDAQ: CATG) is delighted
Physiomics announces appointment of David Evans as Chairman 1st May, 2000 Physiomics
  Physiomics announces appointment of David Evans as Chairman Oxford, UK, 26 August 2005 The Board of Physiomics plc (AIM:PYC), a
Tariquidar Trial Halted 1st January, 1970 Biotracker
  Biotech Tracker News - Tariquidar Trial Halted   
UK biotechs: biting off more than they can chew 1st January, 1970 Datamonitor
UK biotechs: biting off more than they can chew Five non-profitable UK biotech companies may be considering a merger, creating

BioNews Results for Xenova:

TranScrip Partners appoints David Oxlade as Chairman of the Board
Bionity.com:  Nov 5 2009 3:58PM Matching: xenova

Xenova Patents:

US Patent No.Title
7374768 Viral vaccines
5565486 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
5696131 Treatment of cancers
5700804 Pharmaceutical compounds
5750530 Pharmaceutical diketopiperazine compounds

View more Xenova patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 13 individuals from Xenova using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 984 times since April 2007, the link to the organisation's website has been followed 206 times

Recent Search Terms used to find this page: Xenova Ltd | Xenova | Physiomics announces appointment of David Evans as Chairman A New Generation of Bioinformatics | xenova ltd | xenova | xenova | xenova | xenova | xenova | Xenova | .

Search for more companies in Slough

Search for more companies in Berkshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Xenova

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.